Med Diary Journal of Cancer Therapeutics and Oncology Research (MDJCTOR)

Med Diary Journal of Cancer Therapeutics and Oncology Research is an open access, peer-reviewed international journal dedicated to publishing high-quality articles in all areas of cancer research and oncology. The journal serves as a platform for the global scientific and medical community to share innovations, findings, and insights into cancer therapy, prevention, and control.

The journal covers a broad spectrum of topics, including novel treatment strategies, drug development, targeted therapies, immunotherapy, chemotherapy, radiotherapy, and other advanced approaches in oncology. It emphasizes studies that explore the therapeutic use of chemical compounds, biologics, and other agents that demonstrate efficacy across biological systems.

We welcome a wide range of manuscript types, including original research articles, review papers, case reports, short communications, clinical images, editorials, and video articles. Submissions are evaluated based on scientific merit, methodological rigor, and research integrity.

Our audience includes medical and healthcare professionals, clinical practitioners, oncology researchers, academic scholars, and students engaged in cancer-related disciplines. The journal aims to foster knowledge exchange and support the advancement of cancer therapeutics globally.

Subject areas